SNDX

NASDAQ HEALTHCARE

Syndax Pharmaceuticals Inc

$17.83

$0.23 (+1.31%)

Live quote

52w: $12.99 – $25.59

Loading chart…

P/E Ratio—

P/B Ratio104.09

EV/EBITDA—

Debt/Equity—

ROE-1890.34%

ROIC—

Revenue Growth627.84%

Gross Margin—

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company is headquartered in Waltham, Massachusetts.

Own SNDX? Track it here.

Create a free account to add SNDX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account